Print Page     Close Window     

SEC Filings

10-K
SERES THERAPEUTICS, INC. filed this Form 10-K on 03/16/2017
Entire Document
 

IN WITNESS WHEREOF, the parties have executed this First Amendment as of the Amendment Date.

 

SERES THERAPEUTICS, INC.

 

 

 

By:

 

/s/ Roger J. Pomerantz

Name:

 

Roger J. Pomerantz, M.D.

Title:

 

President, Chief Executive Officer and Chairman of the Board

 

EXECUTIVE

 

/s/ John G. Aunins

John G. Aunins

 

2

 


© Seres Therapeutics. All Rights Reserved.